Johnson & Johnson (NYSE:JNJ) is reportedly suing Samsung Bioepis for breach of contract related to the launch of a biosimilar ...
The company's subsidiary has launched the Yesintek biosimilar in the United States. This is one of the first Stelara ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback